The neurology of mTOR
- PMID: 25374355
- PMCID: PMC4223653
- DOI: 10.1016/j.neuron.2014.09.034
The neurology of mTOR
Abstract
The mechanistic target of rapamycin (mTOR) signaling pathway is a crucial cellular signaling hub that, like the nervous system itself, integrates internal and external cues to elicit critical outputs including growth control, protein synthesis, gene expression, and metabolic balance. The importance of mTOR signaling to brain function is underscored by the myriad disorders in which mTOR pathway dysfunction is implicated, such as autism, epilepsy, and neurodegenerative disorders. Pharmacological manipulation of mTOR signaling holds therapeutic promise and has entered clinical trials for several disorders. Here, we review the functions of mTOR signaling in the normal and pathological brain, highlighting ongoing efforts to translate our understanding of cellular physiology into direct medical benefit for neurological disorders.
Figures
Similar articles
-
Role of the mTOR signaling pathway in epilepsy.J Neurol Sci. 2013 Sep 15;332(1-2):4-15. doi: 10.1016/j.jns.2013.05.029. Epub 2013 Jun 14. J Neurol Sci. 2013. PMID: 23773767 Review.
-
A recollection of mTOR signaling in learning and memory.Learn Mem. 2013 Sep 16;20(10):518-30. doi: 10.1101/lm.027664.112. Learn Mem. 2013. PMID: 24042848 Review.
-
mTOR in Brain Physiology and Pathologies.Physiol Rev. 2015 Oct;95(4):1157-87. doi: 10.1152/physrev.00038.2014. Physiol Rev. 2015. PMID: 26269525 Review.
-
mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.Int J Mol Sci. 2018 Jul 30;19(8):2226. doi: 10.3390/ijms19082226. Int J Mol Sci. 2018. PMID: 30061532 Free PMC article. Review.
-
Mammalian target of rapamycin (mTOR) signaling pathway and traumatic brain injury: A novel insight into targeted therapy.Cell Biochem Funct. 2022 Apr;40(3):232-247. doi: 10.1002/cbf.3692. Epub 2022 Mar 8. Cell Biochem Funct. 2022. PMID: 35258097 Review.
Cited by
-
A Two-Hit Approach Inducing Flurothyl Seizures in Fmr1 Knockout Mice Impacts Anxiety and Repetitive Behaviors.Brain Sci. 2024 Aug 31;14(9):892. doi: 10.3390/brainsci14090892. Brain Sci. 2024. PMID: 39335388 Free PMC article.
-
Review of pharmacogenetics of antiseizure medications: focusing on genetic variants of mechanistic targets.Front Pharmacol. 2024 Aug 20;15:1411487. doi: 10.3389/fphar.2024.1411487. eCollection 2024. Front Pharmacol. 2024. PMID: 39228521 Free PMC article. Review.
-
Extra-temporal pediatric low-grade gliomas and epilepsy.Childs Nerv Syst. 2024 Aug 27. doi: 10.1007/s00381-024-06573-8. Online ahead of print. Childs Nerv Syst. 2024. PMID: 39191974
-
Sex, tissue, and mitochondrial interactions modify the transcriptional response to rapamycin in Drosophila.BMC Genomics. 2024 Aug 7;25(1):766. doi: 10.1186/s12864-024-10647-x. BMC Genomics. 2024. PMID: 39107687 Free PMC article.
-
Loss of monopolar spindle-binding protein 3B expression promotes colorectal cancer invasiveness by activation of target of rapamycin kinase/autophagy signaling.World J Gastroenterol. 2024 Jul 14;30(26):3229-3246. doi: 10.3748/wjg.v30.i26.3229. World J Gastroenterol. 2024. PMID: 39086630 Free PMC article.
References
-
- Abs E, Goorden SM, Schreiber J, Overwater IE, Hoogeveen-Westerveld M, Bruinsma CF, Aganovic E, Borgesius NZ, Nellist M, Elgersma Y. TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice. Ann Neurol. 2013;74:569–579. - PubMed
-
- Alfaiz AA, Micale L, Mandriani B, Augello B, Pellico MT, Chrast J, Xenarios I, Zelante L, Merla G, Reymond A. TBC1D7 mutations are associated with intellectual disability, macrocrania, patellar dislocation, and celiac disease. Hum Mutat. 2014;35:447–451. - PubMed
-
- Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu Y-F, Madou MRZ, Marson AG, Mefford HC, Esmaeeli Nieh S, O'Brien TJ, Ottman R, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr EH, Yuskaitis CJ, Abou-Khalil B, Alldredge BK, Bautista JF, Berkovic SF, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent JM, Park K, Poduri A, Scheffer IE, Shellhaas RA, Sherr EH, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Lin Thio L, Venkat A, Vining EPG, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR. De novo mutations in epileptic encephalopathies. Nature. 2013;501:217–221. - PMC - PubMed
-
- Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol. 1997;12:25–31. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
